Roger-Luc Chayer (Image : Tiziano Da Silva / Bestimage)
A truly remarkable piece of news appeared yesterday on news wires and was published by the online magazine Science News, which will please our great Céline Dion. A new miv-cel treatment is reportedly showing strong success against stiff-person syndrome, the disease affecting Céline and putting her career at risk.
What is miv-cel immunotherapy treatment
The miv-cel treatment refers to an experimental approach derived from immunotherapy, more specifically a personalized cell therapy. It is a form of treatment in which the patient’s immune system cells are modified so that they target the mechanisms responsible for certain autoimmune diseases.
How miv-cel works against stiff-person syndrome
In the case of stiff-person syndrome — a rare disease that notably affects Céline Dion — miv-cel is based on a technique similar to CAR-T therapies. Doctors extract immune cells, reprogram them in the laboratory so they eliminate cells producing abnormal antibodies, then reinject them into the body.
The goal is to “reset” the immune system in order to reduce or eliminate symptoms such as severe muscle stiffness and spasms. Early results, still limited, show significant improvements in some patients, but the treatment remains at an experimental stage and is not yet widely available.
Promising results but not yet a cure
The most recent data show that miv-cel has produced spectacular results in some patients, but these are still clinical trials, not an officially recognized “cure.”
In a phase 2 trial involving 26 patients with stiff-person syndrome, the majority experienced major improvements: significantly better mobility, a substantial reduction in symptoms, and above all a complete discontinuation of immunosuppressive treatments in all participants.
Even more striking, some researchers are describing an unprecedented effect: a possible “reset” of the immune system, with disappearance of the mechanisms at the origin of the disease.
There are even very encouraging long-term cases, with patients followed for more than two years continuing to do well, while others have seen their symptoms strongly regress or even disappear.
What can be said today, in a rigorous way: miv-cel treatment has allowed some patients to achieve deep remission, sometimes long-lasting — which is already exceptional for this disease.
A concrete hope for Céline Dion
For Céline Dion, who is surely aware of this news, this could mean a clear improvement in her health condition and a return to a career she loves more than anything, to the great joy of her audience.
The case of Mathieu, member of a Belgian LGBTQ+ association
At 42, Mathieu, based in Brussels, does not immediately put a name on what is happening to him. The early signs are subtle, almost misleading: muscle stiffness in the back, unusual tension in the legs, then spasms that appear without warning. At first, he thinks of stress, fatigue, a poor posture. Nothing that could suggest such a rare diagnosis as stiff-person syndrome.
Then the episodes intensify. A sudden noise, a strong emotion, and his body freezes. “It’s like someone pressing pause,” he says. His muscles contract violently, sometimes to the point of making him fall. Leaving his home becomes a source of anxiety. Crossing a street, getting on a tram, even grocery shopping: every gesture is calculated, anticipated.
The diagnosis comes after months of medical wandering. Rare, little known, the disease often leaves patients in uncertainty. For Mathieu, it is both a shock and a relief. Finally, a name. But also the reality of a chronic, unpredictable disorder that disrupts his daily life.
In his personal life, the impact is immediate. In a relationship with a man for several years, Mathieu sees his emotional balance weakened by the disease. Spontaneous gestures become rarer, outings more complicated, and intimacy itself can be affected by pain, fatigue, and fear of spasms. “You have to relearn everything, even being close to the other person,” he says.
His partner becomes a pillar, but also a direct witness to the most difficult moments. This reality requires constant adjustments: more communication, more patience, and sometimes a redefinition of expectations. The couple moves forward differently, adapting to a disease that does not give warnings.
Today, Mathieu tries to preserve what keeps their relationship going: complicity, humor, and a form of daily solidarity. Treatments ease some crises, without completely eliminating them. He learns to recognize signals, avoid triggers, and slow down.
“The hardest part is not only the disease, it’s what it changes between us,” he says bluntly. But despite the constraints, he refuses to let the disease define their relationship. Like many patients with stiff-person syndrome, he closely follows medical advances, hoping one day to regain a freer life.
Stiff-person syndrome vs multiple sclerosis: what are the differences
At first glance, both conditions belong to the same family: autoimmune diseases, where the body turns against itself. But in practice, their mechanisms and consequences differ significantly.
In stiff-person syndrome, the target is precise: the circuits that regulate muscle tone. The immune system disrupts the chemical balance needed for muscle relaxation, leading to progressive muscle stiffness, sometimes violent spasms, and heightened sensitivity to stress or noise. The body becomes rigid, sometimes dramatically, making movement extremely difficult.
Multiple sclerosis, on the other hand, affects a broader system. It attacks myelin, the protective sheath that allows nerves to transmit signals properly. The result is disrupted communication between the brain and the rest of the body. Symptoms are multiple, changing, and often unpredictable: vision problems, intense fatigue, loss of balance, numbness. The disease typically evolves in relapses, alternating with periods of remission.
Another major distinction is frequency. Stiff-person syndrome remains extremely rare, whereas multiple sclerosis affects millions of people worldwide.
Two autoimmune diseases, therefore, but two very different clinical realities: one stiffens the body until it becomes rigid, the other gradually disrupts the communication of the nervous system.
PUBLICITÉ
READ ALSO